SCYNEXIS delays initiation of new clinical studies using the IV formulation of SCY-078 at FDA’s request Mar 2, 2017
SCYNEXIS Announces Appointment of Industry Veteran Marion McCourt to its Board of Directors Jan 26, 2017
